急性脑梗死合并小腿肌间静脉血栓的临床研究进展
Clinical Research Progress of Acute Cerebral Infarction Complicated with Calf Muscular Venous Thrombosis
DOI: 10.12677/acm.2026.1693034, PDF,   
作者: 王 杰, 金 钊, 王泽生:承德医学院研究生学院,河北 承德;于宏彬, 刘思洋, 刘大伟*:承德市中心医院心胸介入血管外科,河北 承德
关键词: 急性脑梗死;肌间静脉血栓;发病机制;危险分层;抗凝治疗;Acute Cerebral Infarction; Intermuscular Venous Thrombosis; Pathogenesis; Risk Stratification; Anticoagulant Therapy
摘要: 脑梗死后患者因肢体功能障碍、长期卧床及血液高凝状态,下肢静脉血栓形成风险显著升高。其中,肌间静脉血栓(Calf Muscle Vein Thrombosis, CMVT)作为远端深静脉血栓(Deep Vein Thrombosis, DVT)的最常见亚型,在卒中后人群中的真实负担被严重低估。CMVT的自然病程具有双向性:多数可自溶或稳定,但部分可向近端延展,继而诱发肺栓塞(Pulmonary Embolism, PE)。当前国内外指南对脑梗死合并CMVT的防治策略缺乏精准推荐,临床在“预防血栓进展”与“避免颅内出血转化”之间面临两难决策。本文系统回顾近期高质量实证研究,聚焦脑梗死特异性背景下CMVT的流行病学特征、病理机制、诊断策略及临床管理争议,旨在为构建兼顾血栓清除与出血安全的个体化方案提供循证依据。
Abstract: The risk of lower extremity venous thrombosis is significantly increased in patients with cerebral infarction due to limb dysfunction, long-term bed rest and hypercoagulable state. Among them, Calf Muscle Vein Thrombosis (CMVT), as the most common subtype of Deep Vein Thrombosis (DVT), is seriously underestimated in the post-stroke population. The natural course of CMVT is bidirectional: most of them can autolyze or stabilize, but some can extend to the proximal end, which in turn induces pulmonary embolism (PE). The current guidelines at home and abroad lack accurate recommendations for the prevention and treatment strategies of cerebral infarction combined with CMVT, and there is a dilemma between “preventing thrombosis progression” and “avoiding intracranial hemorrhage transformation”. This article systematically reviews recent high-quality empirical studies, focusing on the epidemiological characteristics, pathological mechanisms, diagnostic strategies, and clinical management disputes of CMVT in the context of cerebral infarction specificity, in order to provide evidence-based evidence for the construction of individualized programs that take into account the safety of thrombus removal and bleeding.
文章引用:王杰, 金钊, 王泽生, 于宏彬, 刘思洋, 刘大伟. 急性脑梗死合并小腿肌间静脉血栓的临床研究进展[J]. 临床医学进展, 2026, 16(9): 174-179. https://doi.org/10.12677/acm.2026.1693034

参考文献

[1] 中华医学会神经病学分会. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2022 [J]. 中华神经科杂志, 2022, 55(10): 1071-1110.
[2] Righini, M. and Robert-Ebadi, H. (2024) Management of Isolated Distal Deep Vein Thrombosis. Vasa, 53, 185-192.
https://doi.org/10.1024/0301-1526/a001119
[3] Dennis, M., Sandercock, P., Reid, J., et al. (2013) Effectiveness of Intermittent Pneumatic Compression in Reduction of Risk of Deep Vein Thrombosis in Patients Who Have Had a Stroke (CLOTS 3): A Multicentre Randomised Controlled Trial. The Lancet, 382, 516-524.
[4] Khan, F., Tritschler, T., Kahn, S.R. and Rodger, M.A. (2021) Venous Thromboembolism. The Lancet, 398, 64-77.
https://doi.org/10.1016/s0140-6736(20)32658-1
[5] Dhanesha, N., Ansari, J., Pandey, N., Kaur, H., Virk, C. and Stokes, K.Y. (2023) Poststroke Venous Thromboembolism and Neutrophil Activation: An Illustrated Review. Research and Practice in Thrombosis and Haemostasis, 7, Article ID: 100170.
https://doi.org/10.1016/j.rpth.2023.100170
[6] Houghton, D.E., Ashrani, A.A., Liedl, D.A., et al. (2021) Reduced Calf Muscle Pump Function Is a Risk Factor for Venous Thromboembolism: A Population-Based Cohort Study. Blood Advances, 5, 2979-2986.
[7] Stevens, S.M., Woller, S.C., Kreuziger, L.B., Bounameaux, H., Doerschug, K., Geersing, G., et al. (2021) Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest, 160, e545-e608.
https://doi.org/10.1016/j.chest.2021.07.055
[8] 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版) [J]. 中华普通外科杂志, 2017, 32(9): 807-812.
[9] Barbar, S., Noventa, F., Rossetto, V., Ferrari, A., Brandolin, B., Perlati, M., et al. (2010) A Risk Assessment Model for the Identification of Hospitalized Medical Patients at Risk for Venous Thromboembolism: The Padua Prediction Score. Journal of Thrombosis and Haemostasis, 8, 2450-2457.
https://doi.org/10.1111/j.1538-7836.2010.04044.x
[10] Di Nisio, M., van Es, N. and Büller, H.R. (2016) Deep Vein Thrombosis and Pulmonary Embolism. The Lancet, 388, 3060-3073.
https://doi.org/10.1016/s0140-6736(16)30514-1
[11] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
[12] Seiffge, D.J., Cancelloni, V., Räber, L., Paciaroni, M., Metzner, A., Kirchhof, P., et al. (2024) Secondary Stroke Prevention in People with Atrial Fibrillation: Treatments and Trials. The Lancet Neurology, 23, 404-417.
https://doi.org/10.1016/s1474-4422(24)00037-1
[13] Maraziti, G., Mosconi, M.G. and Paciaroni, M. (2024) Comparative Study of Venous Thromboembolic Prophylaxis Strategies in Hemorrhagic Stroke: A Systematic Review and Network Meta-Analysis. International Journal of Stroke, 19, 973-980.
https://doi.org/10.1177/17474930241248542
[14] 李超, 姜英玉, 张心邈, 等. 缺血性卒中后出血转化的影响因素分析[J]. 中国卒中杂志, 2023, 18(9): 1079-1084.
[15] Fischer, U., Koga, M., Strbian, D., Branca, M., Abend, S., Trelle, S., et al. (2023) Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. New England Journal of Medicine, 388, 2411-2421.
https://doi.org/10.1056/nejmoa2303048
[16] Ageno, W., Bertù, L., Bucherini, E., Camporese, G., Dentali, F., Iotti, M., et al. (2022) Rivaroxaban Treatment for Six Weeks versus Three Months in Patients with Symptomatic Isolated Distal Deep Vein Thrombosis: Randomised Controlled Trial. BMJ, 379, e072623.
https://doi.org/10.1136/bmj-2022-072623